Literature DB >> 1850208

Outcomes for cocaine abusers after once-a-week psychosocial therapy.

S Y Kang1, P H Kleinman, G E Woody, R B Millman, T C Todd, J Kemp, D S Lipton.   

Abstract

OBJECTIVE: The authors studied the efficacy of once-weekly psychotherapy, family therapy, or group therapy led by paraprofessionals among patients with cocaine use disorders.
METHOD: Of subjects who sought outpatient treatment, 168 consented to participate in the study and were each randomly assigned to one of the three forms of therapy; 122 patients were interviewed 6-12 months later. Their pre- and posttreatment scores on the Addiction Severity Index were compared.
RESULTS: Significant improvements were observed for the cohort as a whole, but virtually all of the improvement was restricted to the 23 subjects (19%) who were not using cocaine at follow-up. There was a strong relationship between abstinence from cocaine use and absence of addiction-related problems, especially psychiatric symptoms and family problems.
CONCLUSIONS: The results of the study indicate that outpatient therapy once a week is ineffective for cocaine use disorder. The 19% abstinence rate probably represents spontaneous remission among patients with enough motivation to seek treatment, as the number of therapy sessions attended was not related to improvement. Either an intense level of outpatient contact or residential treatment followed by aftercare is probably needed, at least initially, while the patient is attempting to initiate and sustain abstinence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850208     DOI: 10.1176/ajp.148.5.630

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

1.  Managed care and outpatient substance abuse treatment intensity.

Authors:  C H Lemak; J A Alexander
Journal:  J Behav Health Serv Res       Date:  2001-02       Impact factor: 1.505

2.  Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states.

Authors:  Rajita Sinha; Makram Talih; Robert Malison; Ned Cooney; George M Anderson; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

3.  Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals.

Authors:  Helen Fox; Mehmet Sofuoglu; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2015-01-07       Impact factor: 4.153

Review 4.  Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments.

Authors:  James J Mahoney
Journal:  Exp Clin Psychopharmacol       Date:  2018-12-17       Impact factor: 3.157

Review 5.  The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.

Authors:  Helen Fox; Rajita Sinha
Journal:  Adv Pharmacol       Date:  2014

Review 6.  Behavioral therapies for drug abuse.

Authors:  Kathleen M Carroll; Lisa S Onken
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

7.  Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.

Authors:  Helen C Fox; Dongju Seo; Keri Tuit; Julie Hansen; Anne Kimmerling; Peter T Morgan; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2012-01-09       Impact factor: 4.153

8.  Supportive-Expressive Psychodynamic Therapy for Cocaine Dependence: A Closer Look.

Authors:  Paul Crits-Christoph; Mary Beth Connolly Gibbons; Robert Gallop; Sarah Ring-Kurtz; Jacques P Barber; Matthew Worley; Julie Present; Bridget Hearon
Journal:  Psychoanal Psychol       Date:  2008-07-01

9.  Substance user treatment dropout from client and clinician perspectives: a pilot study.

Authors:  Rebekka S Palmer; Mary K Murphy; Alessandro Piselli; Samuel A Ball
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

Review 10.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.